Table I.
Blood Glucose Monitoring (BGM) and HbA1c Pre- and PostTreatment
| Subject | BGM times per day |
HbA1c % |
|||
|---|---|---|---|---|---|
| First week of treatment | Last week of treatment | Intake | End of treatment | 3 months after treatment | |
| 01 | 1.2 | 6.3 | 10.9 | 8.7 | 11.1 |
| 02 | 6.7 | 10.0 | 8.4 | 8.4 | 8.1 |
| 03 | 0.8 | 3.3 | 13.6 | 10.2 | 12.3 |
| 04 | 2.4 | 7.1 | 10.2 | 8.8 | 7.9 |
| 05 | 3.7a | 11.9 | 10.4 | 9.2 | |
| 06 | 4.4 | 6.7 | 8.5 | 9.0b | 8.5 |
| 07 | 7.0 | 6.7 | 14.0c | 10.6 | 10.3 |
| 08 | 3.6 | 4.4d | 11.1 | 10.1 | |
| 09 | 3.7 | 6.6 | 14.0c | 8.8 | 11.3 |
| 10 | 3.7 | 5.9e | 9.5 | 8.6 | 9.3 |
| 11 | 0.6a | 14.0c | 8.9 | 8.5 | |
| 12 | 5.9 | 1.3e | 14.0c | 10.3 | |
| 13 | 5.7 | 7.6 | 16.8b | 9.1 | 9.9 |
| 14 | 4.6 | 6.1 | 9.9 | 7.9 | |
| 15 | 4.5 | 7.6 | 8.6 | 8.0 | 8.2 |
| 16 | 4.1 | 7.7 | 12.2 | 7.7 | 11.6 |
| 17 | 4.0 | 6.9 | 9.9 | 9.4b | 10.3b |
| M (SD) | 4.1 (1.9) | 6.3 (2.0) | 11.6 (2.5) | 9.1 (0.9) | 9.8 (1.4) |
aThese two participants did not complete treatment and did not provide meter data at the end of treatment assessment.
bValue obtained via laboratory blood test.
cValues of “>14.0” using point of care testing were scored as 14.0 for analyses.
dThis participant moved away unexpectedly in week 9 of treatment and did not have access to a computer. This participant’s week 9 data were used above as the end of treatment value.
eThese two participants did not complete treatment but did provide meter data at the end of treatment assessment.